The Misbranding of Vioxx Results In A Nearly $1 Billion Resolution
Last week the Justice Department announced that Merck, Sharp, & Dohme, an American pharmaceutical company, has agreed to resolve criminal charges and civil claims in relation to their promotion and marketing of the painkiller, Vioxx (rofecoxib) by paying $950 million. Yes, you read that right; just shy of $1 billion. Under the resolution terms, Mereck …
